iD Collective has been selected to support the launch of Melrose FutureLab's NMN (Nicotinamide Mononucleotide) product line.
The agency will support the brand across brand, communications, advertising, media buying, and campaign strategy, with a focus on driving awareness, education, and cultural relevance around longevity science in Australia.
iD Collective's Executive Director, Amanda Booth, said: "Longevity is fast becoming one of the most important conversations in wellness and Melrose FutureLab is leading it in a credible accessible way. We're proud to support the brand at such a pivotal point and help bring this next generation of health innovation into the mainstream."